The Therapeutic Potential of Melatonin in Neurological Disorders

被引:4
|
作者
Bhavsar, Bhavini [1 ]
Farooq, Muhammad U. [2 ]
Bhatt, Archit [2 ]
机构
[1] Michigan State Univ, Dept Internal Med, E Lansing, MI 48824 USA
[2] Michigan State Univ, Dept Neurol & Ophthalmol, A-217 Clin Ctr, E Lansing, MI 48824 USA
关键词
Melatonin; neurological disorders;
D O I
10.2174/187221409787003001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Melatonin (N-acetyl-5- methoxytryptamine) is a pineal gland hormone, synthesized from amino acid L-tryptophan. Other tissues including retina, skin, and gastrointestinal tract also synthesize it. It is secreted into the cerebrospinal fluid and circulatory system in a circadian pattern. Its production is light: dark dependent and its levels are low during the day and maximal during the hours of darkness. It plays an important role in different physiological and pathophysiological processes in the brain, which includes regulation of biological rhythms and seasonal reproduction. Its biological activity is associated with its action on melatonin receptors - ML-1 and ML-2. It has antioxidant and neuroprotective propertities and potential therapeutic role in different neurological disorders. Melatonin has been used as a sleep-promoting agent; more recently it has also been used in headache, movement disorders, neuropathic pain, and seizure disorders. In this review, some recent patents also discussed.
引用
收藏
页码:60 / 64
页数:5
相关论文
共 50 条
  • [41] Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review
    Singh, Kuldeep
    Bhushan, Bharat
    Chanchal, Dilip Kumar
    Sharma, Satish Kumar
    Rani, Ketki
    Yadav, Manoj Kumar
    Porwal, Prateek
    Kumar, Shivendra
    Sharma, Ashwani
    Virmani, Tarun
    Kumar, Girish
    Noman, Abdullah Al
    BEHAVIOURAL NEUROLOGY, 2023, 2023
  • [42] Therapeutic potential of Bergenin in the management of neurological-based diseases and disorders
    Rezaiezadeh, Hojjat
    Langarizadeh, Mohammad Amin
    Tavakoli, Marziye Ranjbar
    Sabokro, Mohammad
    Banazadeh, Mohammad
    Kohlmeier, Kristi A.
    Shabani, Mohammad
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (11) : 8349 - 8366
  • [43] An Overview of Chemistry, Kinetics, Toxicity and Therapeutic Potential of Boldine in Neurological Disorders
    Likhit Akotkar
    Urmila Aswar
    Ankit Ganeshpurkar
    Ritik Raj
    Atmaram Pawar
    Neurochemical Research, 2023, 48 : 3283 - 3295
  • [44] GPR56: A potential therapeutic target for neurological and psychiatric disorders
    Qi, Wang
    Guan, Wei
    BIOCHEMICAL PHARMACOLOGY, 2024, 226
  • [45] Exploring the Therapeutic Potential of Peritoneal Dialysis (PD) in the Treatment of Neurological Disorders
    Cheng, Muyuan
    Ding, Yuchuan
    Kim, Enoch
    Geng, Xiaokun
    CELL TRANSPLANTATION, 2024, 33
  • [46] Therapeutic Potential of Vasoactive Intestinal Peptide and its Receptors in Neurological Disorders
    White, Caitlin M.
    Ji, Sunggoan
    Cai, Huan
    Maudsley, Stuart
    Martin, Bronwen
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2010, 9 (05) : 661 - 666
  • [47] Beyond boundaries: The therapeutic potential of exosomes in neural microenvironments in neurological disorders
    Rasouli, Arefe
    Roshangar, Leila
    Hosseini, Mohammadbagher
    Pourmohammadfazel, Amir
    Nikzad, Sadeneh
    NEUROSCIENCE, 2024, 553 : 98 - 109
  • [48] Nesfatin-1: A Biomarker and Potential Therapeutic Target in Neurological Disorders
    Zhou, Siyu
    Nao, Jianfei
    NEUROCHEMICAL RESEARCH, 2024, 49 (01) : 38 - 51
  • [49] Therapeutic apheresis in neurological disorders
    Weinstein, R
    JOURNAL OF CLINICAL APHERESIS, 2000, 15 (1-2) : 74 - 128
  • [50] THERAPEUTIC PLASMAPHERESIS IN NEUROLOGICAL DISORDERS
    TOYKA, KV
    AKTUELLE NEUROLOGIE, 1984, 11 (04) : 114 - 117